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Abstract
We aimed to identify genetic variants associated with cortical bone thickness (CBT) and bone mineral density (BMD) by
performing two separate genome-wide association study (GWAS) meta-analyses for CBT in 3 cohorts comprising 5,878
European subjects and for BMD in 5 cohorts comprising 5,672 individuals. We then assessed selected single-nucleotide
polymorphisms (SNPs) for osteoporotic fracture in 2,023 cases and 3,740 controls. Association with CBT and forearm BMD was
tested for ,2.5 million SNPs in each cohort separately, and results were meta-analyzed using fixed effect meta-analysis. We
identified a missense SNP (Thr.Ile; rs2707466) located in the WNT16 gene (7q31), associated with CBT (effect size of 20.11
standard deviations [SD] per C allele, P = 6.261029). This SNP, as well as another nonsynonymous SNP rs2908004 (Gly.Arg),
also had genome-wide significant association with forearm BMD (20.14 SD per C allele, P = 2.3610212, and 20.16 SD per G
allele, P = 1.2610215, respectively). Four genome-wide significant SNPs arising from BMD meta-analysis were tested for
association with forearm fracture. SNP rs7776725 in FAM3C, a gene adjacent to WNT16, was associated with a genome-wide
significant increased risk of forearm fracture (OR = 1.33, P = 7.361029), with genome-wide suggestive signals from the two
missense variants in WNT16 (rs2908004: OR = 1.22, P = 4.961026 and rs2707466: OR = 1.22, P = 7.261026). We next generated a
homozygous mouse with targeted disruption of Wnt16. Female Wnt162/2 mice had 27% (P,0.001) thinner cortical bones at
the femur midshaft, and bone strength measures were reduced between 43%–61% (6.5610213,P,5.961024) at both femur
and tibia, compared with their wild-type littermates. Natural variation in humans and targeted disruption in mice demonstrate
that WNT16 is an important determinant of CBT, BMD, bone strength, and risk of fracture.
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Introduction
Osteoporosis is a common skeletal disease characterized by
reduced areal bone mineral density (BMD) and defects in the
microarchitecture of bone, resulting in an increased risk of fragility
fracture [1]. Osteoporotic fractures affect between one third to one
half of white women [2] and currently incur direct costs exceeding
$19 billion per year in the United States alone [3]; and this socio-
economic burden is increasing with the ageing of industrial
societies [4].
Twin and family studies have revealed that genetic factors can
explain up to 85% of the variation in peak BMD [5,6]. Since
2007, we and others have published several genome-wide
association studies (GWAS) for osteoporosis and related traits
[7,8,9,10,11,12,13,14] identifying multiple common variants
associated with BMD and highlighting biologic pathways that
influence BMD.
Most osteoporotic fractures occur at peripheral sites, mainly
containing cortical bone, after the age of 65 [15]. As indicated by a
recent study, bone loss at this age is mainly due to loss in cortical
and not trabecular bone [16]. In human cadaver femurs, cortical
bone has been reported to be the main determinant of the femoral
neck bone strength, while trabecular bone only contributes
marginally to bone strength at this site [17]. Evidence implicating
cortical thinning as a risk factor for hip fracture has also been
presented [18]. The heritability for cortical thickness, measured
using computed tomography, has been reported to be as high as
51% [19].
BMD is a complex trait, obtained from a 2-dimensional
projectional scan of the given bone with dual x-ray absorpti-
ometry (DXA). Although BMD is the most clinical useful
measure for diagnosing bone fragility (osteoporosis), it fails to
provide a detailed skeletal phenotype necessary to discern traits
such as bone geometry and volumetric BMD (vBMD) [20].
Most of the loci or genes identified have been associated with
BMD at lumbar spine and/or femoral neck, sites rich in
trabecular bone. Therefore, we hypothesized that investigating
BMD at the forearm, a primarily cortical bone site, as well
cortical bone thickness, a trait with high heritability, would
serve as successful strategies to identify novel bone related
genetic loci.
Forearm fractures are among the most common fractures,
affecting 1.7 million individuals per year. In contrast to hip
fractures [21], forearm fractures have been shown to be highly
heritable, with estimates of 54% [22]. To our knowledge, no GWA
studies for cortical bone thickness, forearm BMD or fractures have
been published. Importantly, we are aware of only one previous
locus [12] that has been associated with risk of fracture even in
large-scale meta-analytic efforts at a genome-wide significant level
(reviewed previously) [23,24,25].
In this study, we performed two separate GWA meta-analyses in
order to identify loci for cortical bone thickness of tibial diaphysis
and BMD at the distal radius. Firstly, we performed a GWA study
of three large and well-characterized independent discovery
cohorts of 5,878 samples with the aim of identifying genetic loci
for cortical thickness. SNPs meeting GWAS significance in the
discovery meta-analysis were also tested for association in a large
replication cohort (N = 1032). In the second and separate GWA
meta-analysis, we combined genome-wide association results of
5,672 samples with BMD measurement at the forearm site from
five cohorts; we then sought evidence of association of selected
genome-wide significant signals in three cohorts comprising 5,763
individuals for forearm fracture.
To determine the possible functional role of the identified genes
on cortical bone thickness and bone strength, we generated mice
with inactivated genes and investigated their skeletal phenotype.
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The resultant findings increase our understanding of the genetic
basis of osteoporosis and osteoporotic fracture.
Results
GWAS Meta-Analysis of Cortical Thickness
Anthropometrics, and bone variables for the three discovery
GWAS cohorts and one replication cohort are presented in Table
S1. Marked deviation from the null distribution amongst the
lowest observed p-values were observed for the meta-analysis
results (Figure S1). The results showed that the greatest evidence
for association between genetic variation and tibial cortical
thickness was seen for rs9525638 on chromosome 13, slightly
upstream of the RANKL gene (20.11 standard deviations [SD] per
T allele, P = 3.3610210) (Table 1, Figure S2 and Figure S3). The
second strongest genetic signal (rs2707466) for cortical thickness
was located at the WNT16 locus (20.10 SD per C allele,
P = 5.961029) (Table 1, Figure 1 and Figure S2). The SNP
rs2707466 represents a missense polymorphism (Thr.Ile) located
in the fourth exon of WNT16.
We selected our top two regions, the RANKL and WNT16 loci,
with SNPs with P,161025 and carried out analyses conditional
on the most associated SNPs in each region: rs9525638 and
rs2707466, respectively. When conditioning on the most signifi-
cant SNP in the WNT16 region (rs2707466) an additional
suggestive signal (rs12706314 in C7orf58, P condition = 7.361025)
appeared, but did not achieve genome-wide significance. Using a
similar conditional analysis (with rs9525638) for the RANKL locus,
no additional SNPs with an independent signal appeared.
Cortical Thickness Replication Study
Two SNPs (rs9525638, rs2707466) were selected for replication
in the MrOS Sweden cohort. In the replication stage, SNP
rs2707466 at the WNT16 locus was significantly associated with
tibial cortical thickness (20.11 SD per C allele, P = 0.008), whilst
no strong evidence of association was seen for rs9525638 near the
RANKL locus although the estimated effect was in the same
direction as in the discovery meta-analysis (Table 1). Thus,
rs2707466 was the only SNP that was significantly associated with
cortical thickness in both the discovery and replication cohorts
(combined 20.11 SD per C allele, P = 1.5610210). Therefore,
further analysis of associations with bone traits was constrained to
rs2707466 at the WNT16 locus. Associations between rs2707466
and cortical thickness were highly similar when performed
according to sex (Figure 2). No evidence of a significant impact
of age for the association between rs2707466 and cortical thickness
was found (ALSPAC (young) vs. GOOD, YFS and MrOS
combined (adult and older): 20.09 SD vs. 20.13 SD per C allele,
P = 0.135, for heterogeneity between the two groups). In the
combined meta-analysis, rs2707466 was not associated with either
cortical vBMD or periosteal circumference (Table S2). In the
GOOD cohort, rs2707466 was associated with cortical bone
thickness also at the radius (20.12 SD per C allele, P = 0.008).
GWAS Meta-Analysis of Forearm BMD
The information of the five forearm BMD cohorts is presented
in Table S3. A quantile-quantile plot of the observed P values
showed a clear deviation at the tail of the distribution from the null
distribution (Figure S4). The meta-analysis revealed that 54 SNPs
within the 7q31 locus had genome-wide significant associations
(P,4.661028) with forearm BMD (Table S4 and Figure S5). The
most significant SNP was at rs2536189 (20.16 SD per C allele,
P = 8.5610216). Two common amino acid substitutions at
WNT16, rs2908004 (Gly.Arg) (20.16 SD per G allele,
P = 1.2610215) and rs2707466 (Thr.Ile as described in cortical
thickness study) (20.14 SD per C allele, P = 2.3610212) also
demonstrated genome-wide significance (Table 2). The highlight-
ed locus at 7q31 locus included genome-wide significant SNPs at
the WNT16 (wingless-type MMTV integration site family,
member 16), FAM3C (family with sequence similarity 3, member
C) and C7orf58 (chromosome 7 open reading frame 58) genes
(Figure 3). To identify the possible secondary signals in this locus,
we carried out a conditional analysis. When conditioning on
rs2536189, the most significant SNP at WNT16 for BMD, an
additional signal (rs1554634 in C7orf58, P = 7.861028) was
highlighted at a genome-wide suggestive level of association
(Figure S6). This SNP is in LD with rs12706314 in C7orf58
(r2 = 0.35 and D’ = 0.72 in HapMap CEU), which showed
suggestive association with cortical thickness when conditioning
on the top signal for cortical thickness.
Forearm Fracture Association Study
In order to investigate whether the variants showing association
with forearm BMD also have an effect on the risk of forearm
fracture, we selected 4 genome-wide significant SNPs from the
BMD analysis for de novo genotyping in samples with forearm
fracture and their controls (Table S5), including the two missense
SNPs in WNT16 (rs2707466 and rs2908004), one from FAM3C
(rs7776725) and one from C7orf58 (rs10274324). In the meta-
analysis for osteoporotic fracture, comprising 2,023 forearm
fracture cases and 3,740 controls, from 3 cohorts, we identified
the rs7776725 SNP in FAM3C as being genome-wide significant
for forearm fracture, with each C allele increasing the odds of
fracture by 1.33 (95% confidence interval [CI]: 1.20–1.46, P-
value = 7.361029) (Table 2 and Figure 4). The two missense SNPs
in WNT16 also demonstrated strong associations with risk of
fracture (rs2908004, risk allele G, OR = 1.22 [95% CI: 1.12–1.33],
P-value = 4.961026 and rs2707466, risk allele C, OR = 1.22 [95%
CI: 1.11–1.33], P-value 7.261026). SNP rs10274324 from C7orf58
Author Summary
Bone traits are highly dependent on genetic factors. To
date, numerous genetic loci for bone mineral density
(BMD) and only one locus for osteoporotic fracture have
been previously identified to be genome-wide significant.
Cortical bone has been reported to be an important
determinant of bone strength; so far, no genome-wide
association studies (GWAS) have been performed for
cortical bone thickness (CBT) of the tibial and radial
diaphysis or BMD at forearm, a skeletal site rich in cortical
bone. Therefore, we performed two separated meta-
analyses of GWAS for cortical thickness of the tibia in 3
independent cohorts of 5,878 men and women, and for
forearm BMD in 5 cohorts of 5,672 individuals. We
identified the 7q31 locus, which contains WNT16, to be
associated with CBT and BMD. Four SNPs from this locus
were then tested in 2,023 osteoporotic fracture cases and
3,740 controls. One of these SNPs was genome-wide
significant, and two were genome-wide suggestive, for
forearm fracture. Generating a mouse with targeted
disruption of Wnt16, we also demonstrated that mice
lacking this protein had substantially thinner bone cortices
and reduced bone strength than their wild-type litter-
mates. These findings highlight WNT16 as a clinically
relevant member of the Wnt signaling pathway and
increase our understanding of the etiology of osteoporo-
sis-related phenotypes and fracture.
Wnt16, Cortical Bone Thickness, BMD, and Fracture
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was not associated with fracture in this study (P = 0.15). These
results were consistent across the three cohorts (Table S6).
Mouse Gene Deletion Studies
Mice with a gene deletion of Wnt16 (Wnt162/2) appeared
healthy with no discernible morphological or growth defects, and
had normal body weight and femur length at 24 weeks. In
microCT analyses of the femoral diaphysis, male Wnt162/2 mice
had a trend suggestive of reduced cortical thickness (27%,
P = 0.14), and reduced cortical bone polar moment of inertia
(216%, P,0.001) (Table 3); female Wnt162/2 mice had
substantially reduced cortical cross sectional area (236%,
P,0.001) and cortical thickness (227%, P,0.001) and calculated
bone strength (polar moment of inertia, 255%) (Table 3).
Trabecular bone volume fraction (bone volume/total volume), as
measured by microCT of 5th lumbar vertebrae (LV5), was similar
in wild-type and Wnt162/2 mice (Table 3). In three-point bending
tests, measures of bone strength (stiffness, maximal force to
breakage and work to failure) were decreased between 43–61%
(6.5610213,P,5.961024) in Wnt162/2 female mice at both
femur and tibia (Figure 5). However, microCT parameters of the
femoral shaft and LV5 in male wild type and Fam3c2/2 mice did
not reveal any consistent differences across the three targeting
strategies (Table S7).
Discussion
Forearm fractures are a common and costly condition. In two
separate GWASs for forearm BMD and cortical bone thickness
we have identified variants that are genome-wide significant for
these traits and, importantly, for forearm fracture at the 7q31
locus. Further, we have provided functional data from mice
demonstrating that Wnt162/2 mice have reduced cortical bone
thickness and bone strength. These results are among the first to
demonstrate a genome-wide significant locus for osteoporotic
fracture suggesting that this locus is an important genomic
determinant of cortical bone thickness and forearm BMD and
fracture as well.
WNT16 is a member of the wingless-type MMTV integration
site family, which has been reported to mediate signaling via
canonical or non-canonical Wnt pathways. The canonical Wnt
pathway has been shown to regulate bone mass. Specifically, loss
of function mutations in the Wnt-co receptor LRP5, as seen in
osteoporosis pseudoglioma syndrome, result in a dramatic loss in
bone mass [26], while gain of function mutations give rise to
extremely high BMD (5 SD above normal) [27]. Wnt16 has been
proposed to signal via the non-canonical pathway [28], regulating
haematopoetic stem cell specification in zebra fish, but whether
this signaling system involves regulation of osteoblasts, which are
of mesenchymal origin, is unclear. Little is known of the role of
WNT16 in skeletal development and function, but Wnt16 has
previously been implicated in synovial joint development in mice
[29]. Several genes involved in the Wnt pathway have been
previously identified to be associated with BMD by GWAS. These
include known loci CTNNB [10], SOST [30], LRP4 [9,10], LRP5
[8,10], FOXC2 [10], GPR177 [10], and MEF2C [10]. Our study
adds WNT16 to this list of bone-influencing Wnt factors. In
addition to our GWA meta-analyses results for cortical bone
thickness and forearm BMD, we present a functional study
demonstrating that Wnt162/2 mice have a substantial decrease in
cortical bone thickness (27%) and bone strength (43–61%), but not
bone length. Further, Medina et al (accompanying submission)
Figure 1. SNP rs2707466 regional association plot of the discovery genome-wide meta-analysis of cortical thickness. Circles show
GWA meta-analysis p-values, with different colors indicating varying linkage disequilibrium with rs2707466 (diamond).
doi:10.1371/journal.pgen.1002745.g001
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provide data indicating that variation in WNT16 also influences
BMD in children, suggesting that WNT16 may influence peak
bone mass. Importantly, the clinical relevance of these findings at
WNT16 is supported by our observation that WNT16 influences
clinical fractures in humans and bone strength in mice.
In an experimental study using forearms from cadavers, cortical
bone thickness was highly correlated (r = 0.93) to the 3-point
bending failure load and could improve the prediction of this
strength measure, in combination with bone mineral content
derived from DXA [31]. Among individuals suffering a fracture at
the radius, cortical bone thickness at the same site was 33% lower
than in controls, which was the largest difference observed for the
cortical bone traits [32]. The present study constitutes the first
GWA study of cortical bone thickness, a trait with crucial
importance for bone strength. The SNP rs2707466, which causes
a missense amino acid substitution (Thr.Ile) at the WNT16 locus,
was consistently associated with cortical thickness in a meta-
analysis of three large discovery cohorts and in a replication cohort
(combined P = 1.5610210). In the GOOD cohort, the rs2707466
was also associated with cortical bone thickness at the radius, with
an effect size similar to what was seen for the tibia, indicating that
the WNT16 locus affects cortical bone thickness at both the
forearm and leg. Interestingly, the most significant 14 of the 54
genome-wide significant SNPs in the forearm BMD GWAS, were
all in the WNT16 or FAM3C genes, and showed high correlation
with the two WNT16 missense SNPs: rs2908004 and rs2707466
(0.58,r2,1, in HapMap CEU data). This finding might suggest
that the association signals are driven by these coding SNPs in
WNT16. These two missense variants were also strongly associated
with risk of fracture in our study, but did not achieve genome-wide
significance. All together, our results implicate the WNT16 locus as
important for fracture risk, which would likely be mediated via an
effect on cortical bone, particularly the thickness of the cortical
shell.
FAM3C, which is predicted to be expressed in osteoblasts and
encodes a newly identified cytokine necessary for epithelial to
mesenchymal transition and retinal laminar formation in verte-
brates [33]. We identified the SNP rs7776725 within the first
intron of FAM3C to be genome-wide significant for forearm BMD
(P = 8.5610215) and forearm fracture (P = 8.661029). Since the
fracture cohorts do not have available BMD data, except for the
AOGC cohort, which comprised only 7% of the fracture case
population, no meaningful conclusions could be drawn for the
independence of the association between fracture and forearm
BMD. While candidate gene studies have previously described
relationships between genetic variants and fracture [34,35,36], we
are aware of only one other variant that has been demonstrated to
be genome-wide significant for any type of osteoporotic fracture,
arising from the ALDH7A1 gene [12]. Interestingly, SNP
rs7776725 in FAM3C was previously reported to be associated
with speed of sound (SOS) as analyzed by quantitative ultrasound
at the radius (P = 1.0610211) in an un-replicated GWAS carried
out in Asian populations [13]. This SNP was also associated with
BMD in a Caucasian population [37]. The high-throughput
DEXA and microCT screen which initially identified reduced
cortical bone thickness and bone strength in Wnt16 knockout mice
failed to observe any skeletal phenotype changes in three
independent knockouts of mouse Fam3c. Since the sample size of
Fam3c2/2 mice was small (N = 18), the possibility of a false
negative result cannot be excluded. All together, our functional
studies indicate that Wnt16 rather than Fam3c is responsible for the
observed genetic signal arising from this locus. However, we
provide no data as to whether or not gain of functions variants inT
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Fam3c could have effects on the studied bone traits and fracture
risk.
C7orf58 (FLJ21986), which codes for a hypothetical protein, has
recently been identified to be associated with blood pressure in a
study on Nigerians [38]. As an open reading frame, C7orf58 has no
known function. In the forearm GWAS, the other 40 out of the 54
genome wide significant SNPs are from C7orf58, and show low LD
with rs2908004 and rs2707466 (r2,0.2, in HapMap CEU data),
when conditioning for the top SNP (rs2536189) in WNT16,
resulted in an additional signal (rs1554634) in C7orf58. Similarly,
conditioning for rs2707466 at the WNT16 locus, in the GWAS for
cortical bone thickness, resulted in an additional, suggestive signal
(rs12706314, which was in LD with rs1554634) located in C7orf58.
Furthermore, Medina et al (accompanying submission) demon-
strate in a conditional analysis that a separate signal, other than
the signal derived from WNT16,, located in C7orf58 was associated
with total body BMD. Thus, these studies reveal an independent
genetic signal for several bone traits, arising from C7orf58,
indicating a possible functional role of this protein. Even though
our functional studies imply that Wnt16 determines the bone
effects of the 7q31 locus, further studies are necessary to elucidate
the role of C7orf58.
In summary, we provide the first evidence of association of
common variants across the genome with cortical bone thickness,
forearm BMD and forearm fracture. We also provide functional
data implicating WNT16 at this locus. Importantly, our findings
report one of two genome-wide significant variants for osteopo-
rotic fracture. These results suggest a critical role of Wnt signaling
pathway on cortical bone thickness and bone strength determina-
tion as well as fracture susceptibility.
Materials and Methods
Ethics Statement
All study participants provided informed written consent.
Approval by local institutional review boards was obtained in all
studies.
Study Samples of Bone Cortical Thickness GWAS
GOOD cohort. The Gothenburg Osteoporosis and Obesity
Determinants (GOOD) study was initiated to determine both
environmental and genetic factors involved in the regulation of
bone and fat mass [39] [40]. Young men were randomly identified
in the greater Gothenburg area in Sweden using national
Figure 2. The genome-wide meta-analysis with cortical thickness according to sex.
doi:10.1371/journal.pgen.1002745.g002
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population registers, contacted by telephone, and invited to
participate. Enrolled subjects were between 18 and 20 years of
age. There were no other exclusion criteria, and 49% of the study
candidates agreed to participate (n = 1068). Genotypes from 938
individuals passed the sample quality control criteria (Table S8).
We carried out imputation to HapMap2 using Mach 1.0, Markov
Chain Haplotyping [41], giving a total of 2,608,508 SNPs
YFS cohort. The Cardiovascular Risk in Young Finns
Study (YFS) is an ongoing multi-centre follow-up of atheroscle-
rosis risk factors in young Finns [42]. The first cross-sectional
survey conducted in 1980 comprised a total of 3,596 subjects
(83% of those invited) aged 3, 6, 9, 12, 15 and 18 years. The
subjects were randomly selected from the national population
register from five university cities in Finland (Helsinki, Turku,
Tampere, Kuopio and Oulu) and the rural municipalities in
their vicinity. In 2008, 1,884 subjects (1,058 women and 826
men) aged 31–46 years participated in pQCT measurements
organized in five study centers (Turku, Helsinki, Tampere, Oulu
and Kuopio) between February and December 2008. Trained
technologists in each center performed the measurements. The
same pQCT device was used in all study centers (Stratec XCT
2000R). Pregnant women were excluded from the pQCT
measurements. Subjects gave written informed consent. Bone
measures are described in detail elsewhere [43]. Both pQCT
measurements and genotype information were available for
1558 study subjects. Genotype imputation was performed using
MACH 1.0 [41] and HapMap II CEU samples as the reference
set. See more detail in Table S8.
Figure 3. Scatter plots of the observed association of 7q31 locus with forearm BMD. The P values of SNPs (shown as 2log10 values in y-
axis, from the genome-wide single-marker association analysis using the linear regression model) are plotted against their map position (b36) (x-axis).
The color of each SNP spot reflects its r2 with rs2908004. Missense SNPs are plotted as triangles, and other SNPs are plotted as circles.
doi:10.1371/journal.pgen.1002745.g003
Table 2. Association results of forearm BMD meta-analysis and fracture for selected SNPs.
Meta Analysis of BMD GWAS Meta Analysis of Fracture Results
CHR SNP POSITION EA NEA EAF Beta P-Value RA NEA OR (95% CI) P-Value I2 Gene Annotation
7 rs7776725 120820357 T C 0.74 20.17 8.54E215 T C 1.33 (1.20–1.46) 7.27E209 11 FAM3C
7 rs2908004 120757005 G A 0.58 20.16 1.17E215 G A 1.22(1.12–1.33) 4.90E206 0 WNT16 Missense
7 rs2707466 120766325 C T 0.59 20.14 2.25E212 C T 1.22 (1.11–1.33) 7.19E206 0 WNT16 Missense
7 rs10274324 120686577 T G 0.94 20.21 3.82E208 T G 1.13 (0.92–1.35) 1.50E201 0 C7orf58
EA: effect allele; NEA: non-effect allele; EAF: effect allele frequency; RA: risk allele.
See Table S4 for a list of all genome-wide significant SNPs.
doi:10.1371/journal.pgen.1002745.t002
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ALSPAC cohort. The Avon Longitudinal Study of Parents and
their Children (ALSPAC) is a geographically based birth cohort
study investigating factors influencing the health, growth, and
development of children. All pregnant women resident within a
defined part of the former county of Avon in South West England
with an expected date of delivery between April 1991 and
December 1992 were eligible for recruitment, of whom 14,541
were enrolled (http://www.alspac.bris.ac.uk) [44]. Both mothers
and children have been extensively followed from the 8th gestational
week onwards using a combination of self-reported questionnaires,
medical records and physical examinations. Blood samples were
taken and DNA extracted as previously described [45]. 3382 study
subjects had both pQCT measurements and genotype information.
We carried out imputation using MACH 1.0.16, Markov Chain
Haplotyping [41], using CEPH individuals from phase 2 of the
HapMap project as a reference set. See more detail in Table S8.
Study Samples of Bone Cortical Thickness Replication
Study
MrOS Sweden cohort. The Osteoporotic Fractures in Men
(MrOS) study is a prospective multicenter study including older men
in Sweden (3014), Hong Kong (.2000), and the United States
(.6000). In the present study, associations between candidate
polymorphisms and skeletal parameters were investigated in the
Swedish cohort (Table 1), which consists of three sub-cohorts from
three different Swedish cities (n = 1005 in Malmo¨, n = 1010 in
Gothenburg, and n = 999 in Uppsala). Study subjects were
randomly identified using national population registers, contacted
and asked to participate. To be eligible for the study, the subjects
had to be able to walk without assistance, provide self reported data,
and sign an informed consent; there were no other exclusion criteria
[46]. See more detail in Table S8.
Study Samples of Forearm BMD GWAS
5,672 samples from five cohorts of European descent partici-
pated in this meta-analysis (Tables S3 and S9). BMD at forearm in
all cohorts was measured by dual-energy X-ray absorptiometry
following standard manufacturer protocols.
TwinUK1 and TwinUK23 cohorts. TwinsUK (http://
www.twinsuk.ac.uk/) is a population-based registry of British
Twins representative of the general British population [8,36,47].
Genotyping of the TwinUK1 was done by Illumina Human
Hap300, and TwinUK23 by HumanHap610Q. Imputation was
performed using the IMPUTE software package version 2 [48]
based on HapMap2, release 22.
AFOS cohort. The Amish Family Osteoporosis Study (AFOS)
study was designed to identify genetic determinants of osteoporosis
in the Old Order Amish (OOA) population from Lancaster
Figure 4. Forest plots of association of top SNPs for forearm fracture.
doi:10.1371/journal.pgen.1002745.g004
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County, PA USA [49,50]. Genotyping was done using either the
Affymetrix 500K or 6.0 genotyping chip. The Birdseed genotype-
calling algorithm was used. Imputation was performed using
MACH on the HapMap2, rel 22 data.
GOOD cohort. The GOOD study subjects (study inclusion
criteria described under the cortical bone thickness GWA study) were
contacted and invited to participate in a five-year follow-up exam [51].
Forearm BMD measurements were available in 731 men (Table S3).
AOGC cohort. The Anglo-Australasian Osteoporosis Genet-
ics Consortium (AOGC) study collected unrelated individuals with
extreme BMD phenotypes as a powerful strategy for gene
discovery in quantitative traits [11,52]. Genotyping was performed
Figure 5. Decrease of bone strength of Wnt16 knockout mice at femur and tibia. In Femur group, the sample size are 23 wide type (WT)
mice and 13 knock out (KO) mice, and in Tibia group, the sample size are 12 WT mice and 9 KO mice. The P values for each group are shown in the
figure.
doi:10.1371/journal.pgen.1002745.g005
Table 3. Body weight, femoral length, and MicroCT data in Wnt162/2 mice, males (WT = 9; Wnt162/2= 11) and females (WT = 24,
Wnt162/2= 16).
Parameter
Male WT
Mice
Male Wnt162/2
Mice Statistics
Female WT
Mice
Female Wnt162/2
Mice Statistics
Body Weight (grams) 35.461.8 37.661.3 D=q10%, P = 0.35 27.360.8 25.961.3 D=Q5%, P = 0.34
Femur Length (mm) 16.360.2 16.260.2 D=q1%, P = 0.58 16.260.1 16.160.1 D= 0%, P = 0.86
LV5 BV/TV (%) 20.061.7 22.961.1 D=q15%, P = 0.15 15.061.2 16.061.1 D=q7%, P = 0.54
Femur Shaft Total Area (mm2) 1.8360.09 1.6060.08 D=Q13%, P = 0.07 1.5760.04 1.0760.03 D=Q32%, P,0.001
Femur Shaft Bone Area (mm2) 0.9960.04 0.8860.04 D=Q11%, P = 0.08 0.8860.02 0.5660.01 D=Q36%, P,0.001
Femur Shaft Marrow Area (mm2) 0.8460.06 0.7260.06 D=Q15%, P = 0.15 0.6960.03 0.5160.02 D=Q24%, P,0.001
Femur Shaft Cortical Thickness (mm) 25169 23368 D=Q7%, P = 0.14 24664 18664 D=Q27%, P,0.001
Femur Shaft Polar MOI (mm4) 0.50760.047 0.42860.49 D=Q16%, P,0.001 0.37660.016 0.16860.008 D=Q55%, P,0.001
doi:10.1371/journal.pgen.1002745.t003
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using Illumina Infinium II HumHap370CNVQuad chips at the
University of Queensland Diamantina Institute, Brisbane, Aus-
tralia. Subsequent imputation was done based on the HapMap2
release 22 data using MACH program.
Study Samples of Forearm Fracture Association Study
Four genome-wide significant SNPs for forearm BMD were
selected to test the association with forearm fracture in 2,142 cases
and 3,697 controls from three cohorts. Forearm fracture was
defined as fractures resulting from low trauma (such as a fall from
standing height) occurring at the wrist, ulna, radius, forearm, as
well as Colles’ fractures.
UFO cohort. The Umea˚ Fracture and Osteoporosis (UFO)
study is a nested case-cohort, population-based study from Sweden
designed to identify the genetic and gene-by-environmental
determinants of osteoporotic fracture. This cohort is sampled
from a population-based cohort study from Northern Sweden
initiated to identify the risk factors for diabetes and cardiovascular
disease [53,54]. In total, 1,068 cases and 1,218 age-matched
controls were included from this cohort. All fractures were
confirmed by radiographic or surgical report. De-novo genotyping
in the UFO study was undertaken at Kbiosciences (England).
CaMos and ManMc cohort. The Canadian MultiCentre
Osteoporosis study (CaMos) is a population-based prospective
study of 9,423 men and women from across Canada, followed for
fourteen years for osteoporotic outcomes and risk factors [55]. All
fractures in the CaMos study at forearm were confirmed with
radiographic or surgical report. The Manitoba-McGill (ManMc)
fracture study is a population-based cohort of women undergoing
surgical repair of wrist and hip fractures within the Province of
Manitoba, Canada [56]. All individuals had no prior history of
concomitant disease or use of bone-altering drugs. All fractures
occurred at forearm and were confirmed with surgical report.
ManMc was designed to complement the CaMos cohort by
recruiting individuals suffering osteoporotic fractures in the most
heritable age range (prior to age 70) and compare them to controls
from the CaMos cohort that had not suffered an osteoporotic
fracture after up to fourteen years of follow-up and subjects
reaching at least 70 years of age. Weight and height at time of
fracture are not collected for these study participants. 800 cases
with forearm fracture and 855 controls were included from the
combined CaMos/ManMc study. De novo genotyping for the
CaMos and ManMc cohorts at the 4 SNPs assessed for fracture
was undertaken at Kbiosciences (England).
AOGC cohort. This in silico association study included 155
forearm fracture cases and 1,672 controls from the AOGC GWAS
[11]. In some samples the level of trauma was not known. In these
cases, if the fracture occurred after age 60 years, it was considered
to be an osteoporotic low trauma fracture, fractures occurring
prior to this age with unknown trauma level were conservatively
excluded. Fracture cases were identified by self-report.
Statistical Analysis
Genome-wide meta-analysis and replication method for
bone cortical thickness study. The ALSPAC (n = 3382), YFS
(n = 1558) and GOOD (n = 938) discovery cohorts contributed to
the genome-wide meta-analysis. We analyzed only those imputed
SNPs which had a minor allele frequency of .0.01 and an r2
imputation quality score of .0.3 in all 3 sets (n = 2,401,124). We
carried out genome-wide association analyses for cortical
thickness using additive linear regression in Mach2QTL for
ALSPAC, ProbABEL [57] for YFS and using GRIMP [58] for
the GOOD analyses. We included age, sex, height and weight(ln)
as covariates. We carried out meta-analyses of the results from
the three cohorts using the inverse variance method. Standard-
ized betas and standard errors from each study are combined
using a fixed effect model which weights the studies using the
inverse variance and applying genomic control to individual
studies and the combined results. Genome-wide significance was
taken to be p,561028. We selected one SNP from each
independent region that had a p,561028 for replication in the
MrOS Sweden cohort. We also repeated the analyses in each of
the three discovery cohorts, conditional on these top SNPs, to
identify any additional independent associations in the regions.
Additive linear regression analyses were carried out for the
associations between these SNPs and cortical thickness in SPSS
Statistics 17.0 for MrOS Sweden, using age, sex, height and
weight(ln) as covariates. The results of all four cohorts were
combined using a fixed effects inverse-variance meta-analysis in
Stata (version 11.2). Correlations between bone traits in the
MrOS cohort were tested and presented as Spearman’s rank
correlation coefficients (rho).
Genome-wide meta-analysis method for forearm BMD
study. All cohorts independently conducted the association
analysis of SNP allele dosage with standardized BMD residuals,
while adjusting for age, age2, gender, weight and population
substructure where applicable, for centre of recruitment (AOGC),
and for family structure in cohorts with family members. The
analyses were performed for men and women combined. Details
of each study’s GWAS are found on Table S9. A meta-analysis of
the GWAS results was conducted using the GWAMA software
(Genome-Wide Association Meta Analysis) (http://www.well.ox.
ac.uk/gwama/) [59], with which meta-analyses are performed for
both directly genotyped and imputed SNPs using estimates of the
allelic effect size and standard error for BMD, and estimates of the
allelic odds ratio and 95% confidence interval for fracture. Poorly
imputed SNPs (r2 in MACH,0.3 or proper_info in IM-
PUTE2,0.40) and SNPs with low MAF (,0.01) were excluded.
The summary effect estimates for BMD and fracture risk were
computed using fixed-effects inverse variance meta-analysis [60].
Cochran’s Q statistic and I2 estimates were used to evaluate the
heterogeneity. To control for possible inflation of statistics due to
population stratification and family relations, genomic control was
applied to each study as well as the overall meta-analysis [61].
Statistical significance for genome-wide BMD association study
was set at P,561028.
Fracture association analysis. Four of the 54 genome-wide
significant SNPs, in the forearm BMD GWAS, were selected to
test the association with fracture. The rationale for picking these
SNPs included: 1) Given that the Wnt pathway is central to
osteoporosis etiology, two missense SNPs (rs2908004 and
rs2707466) from WNT16 were selected, considering that missense
SNPs may have more functional consequence than synonymous or
non-coding SNPs, and that these two SNPs can fully tag the top
SNP rs2536189 (r2.0.98); 2) The SNP rs7776725, which is in
FAM3C, was selected because it was previously reported to be
associated with speed of sound through bone, as analyzed by
quantitative ultrasound at the radius [13] and was in only
moderate LD with the rs2908004 (r2 = 0.58); 3) The SNP
rs10274324 was selected based on its genome wide significance
(20.21 SD per T allele, P = 3.861028 for forearm BMD), LD
information (r2 = 0.04 with the top SNP rs2536189) and location
(in C7orf58 gene). Therefore, the SNP selection provided
assessment across all three genes at this locus (WNT16, FAM3C
and C7orf58). SNPs were assessed for association with fracture risk
using logistic regression models adjusted for sex, height and
weight. Age was included as an additional covariate where this was
not controlled for through the study design. Again, a fixed effect
Wnt16, Cortical Bone Thickness, BMD, and Fracture
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meta-analysis was undertaken assessing the effect of allelic dose on
risk of fracture.
Generation of Knockout Mice
Wnt162/2 mice. Mice with a gene deletion of Wnt16 were
generated using homologous recombination techniques. The first
three exons were disrupted, with confirmation by Southern
hybridization analyses (Figure S7). F2 hybrid littermates, derived
from C57BL/6J and 129 SvEv parental strains, were examined at
24 weeks of age.
Fam3c2/2 mice. Three separate knockout strategies were
employed to inactive mouse Fam3c: 1) gene trap disrupting the
intron between the first two exons with confirmation by lack of
gene expression by RT-PCR in kidney and spleen (Figure S8), 2)
homologous recombination removing the first two coding exons
with confirmation by Southern hybridization analysis (Figure S9),
3) homologous recombination involving replacement of the mouse
gene by the human gene resulting in loss of function (Figure S10).
F2 hybrid littermates, derived from C57BL/6J and 129 SvEv
parental strains, were examined at 16 weeks of age. All studies
were performed in accordance with institutional and regulatory
guidelines for animal care.
Imaging. Male and female mice were scanned using a
microCT (Scanco mCT40, Switzerland). The fifth lumbar
vertebrae (LV5) were scanned with a voxel size of 16 mm.
Midshaft femurs were scanned with a voxel size of 20 mm. All
scans used a threshold of 240, an X-ray tube voltage of 55 keV, a
current of 145 microamperes and an integration time of 200
microseconds. Three-point bending tests were performed using
Mach-1TM Micromechanical System A300.100 (Bio Syntech
Canada inc., Laval, Quebec, Canada). The extrinsic parameters
(ultimate force [Fult], stiffness [K or S], and work to failure [W or
U]) were determined from a force-displacement curve. The span
of two support points was 7 mm. The de-formation rate was 50
mm/s.
Statistical analysis. Two-sided student’s t-test was employed
to determine statistical significance of the effect of gene
inactivation for each gender. Results are shown as mean+SEM.
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Figure S1 Quantile-quantile plots of the observed P values
versus the expected P values for association for GWAS Meta-
Analysis of cortical thickness. The scatters in black showed a clear
deviation at the tail of the distribution from the null distribution
(the red line).
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Figure S2 Manhattan plot for GWAS Meta-Analysis of cortical
thickness. Genome-wide P values (2log10 P) of the linear
regression analysis plotted against position on each chromosome.
(DOCX)
Figure S3 SNP rs9525638 regional association plot of the
discovery genome-wide meta-analysis of cortical thickness. Circles
show GWA meta-analysis p-values, with different colors indicating
varying linkage disequilibrium with rs9525638 (diamond).
(DOCX)
Figure S4 Quantile-quantile plots of the observed P values
versus the expected P values for association of Forearm BMD. The
scatters in blue were based on the entire set of SNPs, whereas the
scatters in black were obtained after removing WNT16 region
SNPs (+/2400KB either side of rs2908004). The black line was
the distribution expected if there were no association.
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Figure S5 Manhattan plot for GWAS Meta-Analysis of Forearm
BMD. Genome-wide P values (2log10 P) of the linear regression
analysis plotted against position on each chromosome.
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Figure S6 Scatter plots of the observed association of 7q31 locus
with forearm BMD after condition on the top SNP rs2536189.
The P values of SNPs (shown as 2log10 values in y-axis, from the
genome-wide single-marker association analysis using the linear
regression model) are plotted against their map position (b36) (x-
axis).
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Figure S7 A: Restriction map of the Wnt16 gene and
construction of the neomycin-resistance (neo) vector. Wnt16
exons are shown as filled boxes. Sequence information
(deletion, insertion site, flanking sequence) is provided on the
Taconic Farms website (http://www.taconic.com/wmspage.
cfm?parm1=16 catalogue number TF3785). B: confirmation
by Southern blots.
(DOCX)
Figure S8 A: Retroviral insertion disrupted Fam3c gene prior to
the exon encoding amino acid 19 in a protein of 227 amino acids.
Sequence information (deletion, insertion site, flanking sequence)
is provided on the Taconic Farms website (http://www.taconic.
com/wmspage.cfm?parm1 = 16 catalogue number TF3786). B:
RT-PCR analysis revealed that the wild-type transcript was absent
in the (2/2) mouse analyzed. Larger transcripts were detected at
low levels in both tissues of the (2/2) mouse due to the splicing of
fragments from the retroviral vector into the target transcript as
determined by nucleotide sequence analysis. However, the in-
frame stop codon in the retroviral vector sequence was predicted
to disrupt translation of this transcript.
(DOCX)
Figure S9 A: homologous recombination removing the first two
coding exons of Fam3c. Sequence information (deletion, insertion
site, flanking sequence) is provided on the Taconic Farms website
(http://www.taconic.com/wmspage.cfm?parm1 = 16 catalogue
number TF3787). B: confirmation by Southern hybridization
analysis.
(DOCX)
Figure S10 A: homologous recombination involving replace-
ment of the mouse gene by the human gene resulting in loss of
function of Fam3c. Sequence information (deletion, insertion site,
flanking sequence) is provided on the Taconic Farms website
(http://www.taconic.com/wmspage.cfm?parm1 = 16 catalogue
number TF3788). B: confirmation by Southern hybridization
analysis.
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meta-analysis of cortical bone thickness.
(DOCX)
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study.
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Table S7 Micro CT parameters of the femoral shaft and fifth
lumbar vertebra (LV5) in male wild type and Fam3c2/2 mice.
Data are presented for each of the three KO strategies and also for
the combined cohorts (WT = 2; Fam3c2/2= 4 for each of the
individual cohorts).
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